PRCT
$18.82+2.95%
PROCEPT BioRobotics CorporationStock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
PRCT — PROCEPT BioRobotics Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEE
20.030.040.050.060.070.080.090.0010.0M$18.82—20212022202420252026
2026-10-20
Price$18.82
MA20$19.73
MA50$22.22
Vol2.0M
Key stats#
Price data
- Price
- $18.82
- YTD price return
- -40.18%
- YTD total return
- -40.18%
- Next earnings
- Nov 4, 2026 · After close
- Market cap
- 1.1B
- Enterprise value
- 927.5M
- Shares outstanding
- 57.3M
- 52W low
- $16.67
- 52W high
- $38.11
- From 52W high
- -50.62%
- From 52W low
- +12.93%
- 52W range
- 10%
Volume
- Rel volume
- 0.72×
- 30D volume
- 1.4M
- 30D $ vol
- 25.5M
Fundamentals
- Sales (ttm)
- 337.3M
- Sales/share
- $5.89
- EPS (ttm)
- -$1.95
- FCF (ttm)
- -84.9M
- FCF/share
- -$1.48
- Book value/share
- $5.94
- Net margin
- -32.54%
- ROE
- -32.27%
- ROA
- -22.90%
- Debt / equity
- 0.15×
- Current ratio
- 6.55
Growth (CAGR, ttm) · 10Y
- Sales
- +22.71%+49.15%+98.87%n/a
- Shares
- +2.95%+8.15%+59.23%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +19.20%+37.92%+26.23%n/a
- Book value/share
- -14.38%+19.91%n/an/a
- Price
- -45.82%-12.04%-15.25%n/a
- Total return
- -45.82%-11.69%-14.28%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -9.7×
- Fwd P/E
- -16.1×
- P/S (ttm)
- 3.2×
- P/B (mrq)
- 3.2×
- EV/Sales (ttm)
- 2.7×
- FCF yield (ttm)
- -7.88%
- Buyback yield (realized, 1y)
- -2.95%
- Shareholder yield (realized, 1y)
- -2.95%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 2nd
- P/B
- 3rd
Bar = where today’s multiple sits in PRCT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+2.95%
5D
-1.47%
1M
-2.49%
3M
-2.08%
YTD
-40.18%
1Y
-45.79%
5Y
-56.28%
Financial statements
Open full PRCT financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
